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Summary
 
T cell activation by specific antigen results in a rapid and long-lasting downregulation of trig-
gered T cell receptors (TCRs). In this work, we investigated the fate of downregulated TCR–
CD3-
 
z
 
 complexes. T cells stimulated by peptide-pulsed antigen-presenting cells (APCs) un-
dergo an antigen dose-dependent decrease of the total cellular content of TCR-
 
b
 
, CD3-
 
e
 
, and
 
z
 
 chains, as detected by FACS
 
Ò
 
 analysis on fixed and permeabilized T–APC conjugates and by
Western blot analysis on cell lysates. The time course of CD3-
 
z
 
 chain consumption overlaps
with that of TCR downregulation, indicating that internalized TCR–CD3 complexes are
promptly degraded. Inhibitors of lysosomal function (bafilomycin A1, folimycin) markedly re-
duced 
 
z
 
 chain degradation, leading to the accumulation of 
 
z
 
 chain in large Lamp1
 
1
 
 vesicles.
These results indicate that in T cell–APC conjugates, triggered TCRs are rapidly removed
from the cell surface and are degraded in the lysosomal compartment.
 
T
 
lymphocytes are activated by the engagement of their
clonally expressed TCR with peptide–MHC com-
plexes  displayed on the APC surface. The antigen receptor
of T cells is a multimeric protein complex composed of the
clonotypic 
 
ab
 
 heterodimer, the CD3 
 
gde
 
 chains, and the 
 
z
 
homodimer. Whereas the 
 
ab
 
 heterodimer is responsible
for specific recognition, the associated CD3 chains and 
 
z
 
homodimer are necessary for signal transduction (1). The
assembly of this multichain receptor complex is highly reg-
ulated in T cells, because only correctly assembled recep-
tors can reach the cell surface (2).
Upon conjugation with APCs, T cells undergo a sustained
[Ca
 
2
 
1
 
]
 
i
 
 increase (3, 4) that results from the serial engage-
ment and triggering of many TCRs by a small number of
peptide–MHC complexes (5). A key feature of T cell anti-
gen recognition is that the process of TCR/peptide–MHC
interaction is self-limited by the downregulation of trig-
gered TCR complexes (5, 6). Indeed, downregulation of
triggered TCRs leads to extinction of sustained signaling in
T–APC conjugates and affects T cell responsiveness to fur-
ther antigenic stimulation (6).
The mechanisms that lead to downregulation of trig-
gered TCRs are presently unknown and, in particular, it is
not clear whether these TCRs are indeed degraded or sim-
ply internalized. In this study we investigated the fate of
triggered TCR–CD3 components in human T cells inter-
acting with peptide-pulsed APCs. We report that stimula-
tion by the specific antigen results in rapid and profound
loss of TCR-
 
b
 
, CD3-
 
e
 
, and 
 
z
 
 chain due to degradation in
the lysosomal compartment.
 
Materials and Methods
 
T Cell Clones and APCs.
 
Two DRBI
 
*
 
1104-restricted T cell clones
(KS140 and KS70) specific for the tetanus toxin peptide (TT830–
843; QYIKANSKFIGITE) were used. Autologous Epstein–Barr vi-
rus (EBV)-B cells were used as APCs (4).
 
Intracellular Staining for CD3-
 
e
 
 and 
 
z
 
 Chain.
 
EBV-B cells were
pulsed for 2 h at 37
 
8
 
C with various concentrations of TT830–843
in RPMI, 5% FCS. During the last 10 min, 1 
 
m
 
M BCECF-AM
(2
 
9
 
,7-bis-(carboxyethyl)-5(6
 
9
 
)-carboxyfluorescin; Calbiochem, San
Diego, CA) was added and the cells were washed four times. T cells
were mixed with EBV-B cells at a 1:2 ratio in 200 
 
m
 
l RPMI, 5%
FCS in U-bottomed microplates, centrifuged 1 min at 1,500 rpm
to allow conjugate formation, and incubated at 37
 
8
 
C. In some ex-
periments, T cells were pretreated for 1 h with 10 
 
m
 
g/ml cyclohex-
imide and the drug was present throughout the assay. At different
times, the cells were resuspended, washed in PBS, 0.5 mM EDTA
and fixed for 10 min with 3% paraformaldehyde. The cells were
permeabilized for 10 min at room temperature with washing buffer
(Hepes-buffered PBS containing 0.1% saponin) and stained with
anti-CD3 (TR66; reference 4), anti-V
 
b
 
2 (Immunotech, Marseille,
France), or anti-
 
z
 
 (Santa Cruz Biotechnology, Santa Cruz, CA) in
Hepes-buffered PBS containing 0.1% saponin and 2% BSA (or 5%
FCS), followed by a goat anti–mouse PE-labeled Ab (SBA, Bir-
mingham, AL). The TCR, CD3, and 
 
z
 
 fluorescence were ana-
lyzed on a FACScan
 
Ò
 
 (Becton Dickinson, Mountain View, CA).
EBV-B cells were gated out using both forward and side scatter
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(FSC/SSC) parameters and green BCECF fluorescence. In some
experiments, T cells were conjugated with unstained peptide-
pulsed EBV-B cells; at different times of incubation at 37
 
8
 
C, the
cells were gently resuspended and laid on poly-
 
l
 
-lysine–coated
slides for 10 min at 37
 
8
 
C. The cells were fixed for 10 min with
3% paraformaldehyde, permeabilized for 10 min at room temper-
ature with washing buffer, and stained with an anti-
 
z
 
 (Santa
Cruz) in Hepes-buffered PBS containing 0.1% saponin and 4%
BSA, followed by FITC-labeled goat anti–mouse (SBA) and anti–
human Lamp-1 (provided by Dr. S. Carlsson, Umea University,
St. Louis, MO) followed by Texas Red–labeled goat anti–rabbit
antibody (SBA). The samples were mounted in 90% glycerol–PBS
containing 2.5% 1-4-diazabicyclo (2.2.2) octane (DABCO; Fluka
AG, Buchs, Switzerland). In some experiments, T cells were pre-
treated with 0.5 
 
m
 
M bafilomycin A1 (Calbiochem) or with the
vehicle of the drug only (DMSO 0.5%) for 1 h at 37
 
8
 
C before
conjugate formation. The samples were examined using a Bio-
Rad MRC 1024 confocal microscope (Bio-Rad, Richmond, CA).
 
z
 
 Chain Detection by Western Blot.
 
EBV-B cells were pulsed
with various concentrations of TT830–843. 5 
 
3
 
 10
 
5
 
 T cells were
pretreated for 1 h with 10 
 
m
 
g/ml cycloheximide mixed with 10
 
6
 
EBV-B cells in 500 
 
m
 
l RPMI 5% FCS in U-bottomed tubes,
centrifuged to allow conjugate formation, and incubated at 37
 
8
 
C
for 2 h in the presence of cycloheximide. In some experiments,
T cells were pretreated with 1 
 
m
 
M bafilomycin A1 or with 1 
 
m
 
M
folimycin (Calbiochem) or with the vehicle of the drugs only
(DMSO 1%) for 1 h at 37
 
8
 
C before conjugate formation. The
drugs were present in the culture throughout the assay. At differ-
ent timepoints, the cells were mixed with PBS, lysed in either
ice-cold RIPA buffer containing 1 mM NaVO
 
4
 
 or in prewarmed
Laemmli buffer, sonicated, and boiled. After separation on 12.5%
SDS-PAGE and transfer to nitrocellulose, membranes were blocked
1 h at room temperature with blocking buffer (5% nonfat dry
milk, 0.05% Tween-20 in Tris-buffered saline) and incubated for
1 h with 1 
 
m
 
g/ml anti-
 
z
 
 (Santa Cruz) in blocking buffer. After
washing, the membranes were incubated for 1 h with HRP-labeled
goat anti–mouse Ig (SBA) in blocking buffer. Filters were devel-
oped using an enhanced chemiluminescence detection system
(Amersham, Arlington Heights, IL). Densitometric analysis was
performed using a Computing Densitometer 300A (Molecular
Dynamics, Sunnyvale, CA).
 
TCR Downregulation, IFN-
 
g
 
 Production, and [Ca
 
2
 
1
 
] Measure-
ment.
 
TCR  downregulation, IFN-
 
g
 
 production, and [Ca
 
2
 
1
 
];
were measured as previously described (4, 5). In some experi-
ments, T cells were pretreated with 1 
 
m
 
M bafilomycin A1 or with
1 
 
m
 
M folimycin for 1 h at 37
 
8
 
C before conjugate formation and
the drugs were kept in the culture through all the assay. Control
cultures were done in the presence of vehicle only (1% DMSO).
 
Results
 
Reduced Content of TCR-
 
b
 
, CD3-
 
e
 
, and 
 
z
 
 Chains in T
Cells after Antigen Stimulation.
 
T cells conjugated with
peptide-pulsed APCs undergo a rapid downregulation of
triggered TCR–CD3 complexes that reaches a plateau in
1–2 h (5). To investigate whether downregulated receptors
accumulate inside of T cells or are degraded, we measured
the surface levels and the total cellular content of different
TCR–CD3 components by FACS
 
Ò
 
 analysis. As shown in
Fig. 1, 
 
A–B
 
, in T cells conjugated with peptide-pulsed
APCs the surface level of CD3-
 
e
 
 and the total content of
CD3-
 
e
 
 and 
 
z
 
 chains decreased in a parallel fashion with in-
creasing doses of antigen. Blocking of protein synthesis did
not affect the extent of CD3-
 
e
 
 and 
 
z
 
 chain decrease, dem-
onstrating that disappearance of these components was not
due to a decreased synthesis (Fig. 1 
 
C
 
). Similar results were
observed when levels of CD3-
 
e
 
 and TCR-
 
b
 
 were mea-
sured in a different T cell clone (Fig. 1 
 
D
 
). 
To investigate whether the reduced staining for CD3-
 
e
 
and 
 
z
 
 chain could be due to the localization of triggered re-
ceptors in cellular compartments not accessible to antibodies,
we measured 
 
z
 
 chain expression by Western blot. As shown
in Fig. 2 
 
A
 
, the lysates of T–APC conjugates showed a
dose-dependent decrease in the content of 
 
z
 
 chain. These
results are comparable to those observed by FACS
 
Ò
 
 analysis
(Fig. 1). In addition, the time kinetics of 
 
z
 
 chain decrease
Figure 1. Parallel decrease in surface expression and total cellular con-
tent of TCR-b, CD3-e and z chains in T cells as a function of antigenic
stimulation. T cells (clone KS140) were conjugated at 378C with APCs
pulsed with various doses of peptide. After 2 h the cells were either fixed
and stained with anti-CD3-e or anti-Vb2, or fixed, permeabilized, and
stained with anti-CD3-e, anti-Vb2, or anti z. (A) Staining for total CD3-e
(left) and z (right) in T cells conjugated with unpulsed or peptide-pulsed
APCs. (B and C) Levels of surface CD3-e (s), total CD3-e (d) and total
z (m) chains as a function of antigen concentration. In C, T cells were
pretreated for 1 h with cycloheximide and the drug was present through-
out the assay. (D) Levels of surface and total Vb2 and CD3-e in T cell
clone KS70 stimulated with 100 nM (diagonal stripes) or 10 mM (empty)
peptide expressed as percent of the staining of unstimulated cells (closed).1861 Valitutti et al. Brief Definitive Report
parallels that of surface TCR downregulation (5, 6) reach-
ing a plateau in about 2 h (Fig. 2 B).
The above results demonstrate that TCR triggering by
specific antigen results in a net decrease in the cellular con-
tent of TCR and CD3-e and z molecules. This indicates
that downregulated TCR–CD3-z complexes are promptly
degraded.
Lysosomal Degradation of CD3-z in Activated T Cells. A well-
known mechanism for the inactivation of hormone and
growth factor receptors is their internalization upon ligand
binding followed by their degradation in lysosomes (7). To
find whether triggered TCRs are degraded via a similar
mechanism we stimulated T cells with peptide-pulsed APCs
in the presence of bafilomycin A1 or folimycin, drugs that
affect lysosomal function by increasing lysosomal pH (8, 9).
These drugs do not interfere with TCR downregulation,
sustained [Ca21]i increase, and IFN-g production (Fig. 3),
indicating that they are not toxic for the T cell biological
response. However, bafilomycin A1 and folimycin dramat-
ically inhibited z chain degradation as detected by Western
blot analysis on total cell lysates (Fig. 4). The inhibition of z
chain degradation by bafilomycin A1 and folimycin was
also observed when protein synthesis was blocked by pre-
treating T cells with cycloheximide (Fig. 4). This result in-
dicates that the effect of bafilomycin A1 and folimycin is
not due to the accumulation of newly synthesized unas-
sembled components, but actually results from a block of
the degradation of triggered receptors.
Figure 2. Dose response and kinetics of antigen-induced z chain loss.
T cells were conjugated in the presence of cycloheximide with APCs
pulsed with various peptide concentrations. At the indicated time points
the cells were lysed and the amount of z chain was measured by Western
blot. (A) z chain loss as a function of antigen concentration. (B) Time
course of z chain loss in T cells conjugated with APC pulsed with 10 mM
peptide.
Figure 3. Bafilomycin A1 and folimycin do not interfere with T cell
activation induced by specific antigen. T cells pretreated for 1 h with ba-
filomycin A1 (j), folimycin (m), or vehicle only (d) were conjugated
with APCs pulsed with various peptide concentrations and the drugs were
left in culture throughout the assay. (A) CD3 downregulation after 4 h;
(B) IFN-g production after 4 h; (C) [Ca21]i increase in T cells conjugated
with unpulsed APC (a and d) with APC pulsed with 25 nM (b and e), or
10 mM peptide (c and f). T cells were either pretreated with bafilomycin
A1 (d, e, f) or with the vehicle only (a, b, c).1862 TCR Degradation in T Cell–APC-specific Conjugates
Morphological Evidence for Targeting of Triggered CD3-z to
the Lysosomes. To identify better the site of TCR–CD3
complex degradation, we investigated by confocal micros-
copy the fate of triggered TCRs. T cells were conjugated with
peptide-pulsed or unpulsed APCs and after 2 h the conju-
gates were fixed, permeabilized, and stained with anti-z
chain antibodies.
In unstimulated T cells most of the z chain is associated
with the plasma membrane and this staining pattern is not
affected by preincubation with bafilomycin A1 (Fig. 5, A,
B, E). In T cells that had been conjugated for 2 h with
peptide-pulsed APCs, the staining was much weaker and
did not show the ring-shaped pattern of z chain surface ex-
pression (Fig. 5 C). Strikingly, when conjugates were
formed in the presence of bafilomycin A1 a dramatic accu-
mulation of z chain was observed in intracellular vesicles
(Fig. 5 D). In these vesicles, most of the internalized z
chain colocalized with the lysosomal marker LAMP-1 (Fig.
5 F). These results demonstrate that upon TCR/peptide–
MHC interaction z chains are promptly removed from the
cell surface and degraded in the lysosomes.
Discussion
In specific T–APC conjugates TCRs are downregulated in
an antigen dose- and time-dependent fashion (5). The reduc-
tion of TCR levels plays an important role in extinguishing
the signaling process and reduces T cell responsiveness to
antigenic stimulation (6). So far, TCR downregulation has
been defined only as a long-lasting disappearance of TCRs
from the cell surface, whereas their fate has not been in-
vestigated. In this work, we demonstrate that triggered
TCR–CD3-z complexes are degraded in the lysosomes af-
ter antigenic stimulation. This conclusion is based on mea-
surements of the total cellular content of TCR-b, CD3-e,
and z chains that are quantitatively lost in an antigen de-
pendent fashion and on the effect of drugs that block lyso-
somal degradation.
Whereas CD3 and TCR are tightly associated, the z
chain, which plays a dominant role in TCR-mediated signal
transduction, is associated to the complex in a loose fashion.
Indeed, whereas z is required for assembly and surface ex-
pression of the TCR (2, 10), it has been proposed that it
may be exchanged on mature receptors (11). Our data
demonstrate that in the process of antigen-induced down-
regulation TCR–CD3 and z chains are irreversibly linked.
Recently, Cai et al. (12) showed that in mouse resting T
cells TCR downregulation is due to internalization rather
than shedding, but degradation of the TCR–CD3 com-
plexes has not been investigated.
The mechanisms involved in TCR downregulation by
specific antigen are presently unknown. It has been shown
that phosphorylation of Ser 126 of the CD3-g chain is both
necessary and sufficient for TCR downregulation induced
by pharmacological stimulation of PKC (13). However, the
mechanisms of TCR downregulation induced by PMA or
specific ligand are fundamentally different, because muta-
tions of CD3-g that abolish PMA-induced downregulation
do not affect ligand-induced downregulation (Salio, M., S.
Valitutti, and A. Lanzavecchia, manuscript in preparation).
As are many other surface receptors, TCR–CD3-z com-
plexes are constitutively internalized and recycled to the
plasma membrane (14, 15). Our results suggest that trigger-
ing by cognate ligand leads to the failure of TCRs to recy-
cle back to the surface due to their targeting to lysosomes.
Among possible signals for targeting triggered TCR com-
plexes to lysosomes, it is interesting to consider ubiquitina-
tion (7, 16). Indeed, ubiquitination of TCR–CD3 subunits
(17) and especially z chains (18), have been demonstrated
following TCR cross-linking.
Figure 4. Antigen-induced degradation of z chain is prevented by ba-
filomycin A1 and folimycin. T cells were pretreated for 1 h with bafilo-
mycin A1 or folimycin in the presence or absence of cycloheximide. The
cells were conjugated with APCs pulsed with 10 mM peptide and total
content of z chain was determined after 2 h by Western blot. The drugs
were present throughout the assay. (A) Western blot. (B) Densitometric
analysis of the bands obtained in the absence (closed) or in the presence
(empty) of cycloheximide.
Figure 5. Triggered CD3-z is targeted to the lysosomes for degradation. T cells were conjugated with either unpulsed APCs (a, b, e) or peptide-pulsed
(10 mM) APCs (c, d, f). T cells were treated with bafilomycin A1 1 h before conjugate formation (b, d, e, f) or with vehicle only (a and c) the drug was
left in culture throughout the assay. After 2 h the conjugates were fixed, permeabilized, and stained with anti-z (green) and anti-Lamp-1 (red).1863 Valitutti et al. Brief Definitive Report1864 TCR Degradation in T Cell–APC-specific Conjugates
What could be the physiological relevance of antigen-
induced TCR degradation? It is interesting to note that the
time kinetics of receptor degradation overlaps with the time
kinetics of sustained [Ca21]i increase and TCR downregu-
lation (Fig. 2; references 5, 6). This indicates that serial
TCR triggering and degradation are ongoing phenomena.
We and others have shown that in T cells undergoing sus-
tained signaling, treatments that terminate the process of
TCR engagement result in the extinction of the signaling
process within a few minutes (4, 19). A rapid degradation
of triggered TCRs could be important to inactivate already
triggered receptors as soon as they have been internalized
while new receptors are interacting with the ligands. As a
consequence, any single TCR would be triggered by a sin-
gle peptide–MHC complex only once and the length of
signaling would reflect the length of the serial receptor en-
gagement. This mechanism could be at work to ensure a
strict control of the extent of T cell activation by a defined
number of antigenic determinants.
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